Cipta Sarana Medika Tbk. vs Era Mandiri Cemerlang Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Era Mandiri Cemerlang Tbk. trades at Rp89 (market cap 74.17B, 17.13M 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 2.2× Era Mandiri Cemerlang Tbk.'s market cap, and Era Mandiri Cemerlang Tbk. is more actively traded (17.13M versus 14.05M). Which is the better fit depends on your goals.
| DKHH | IKAN | |
|---|---|---|
Market Cap | 160.67B | 74.17B |
Volume | 14.05M | 17.13M |
Lot | 140.49K | 171.3K |
Turnover | 899.67M | 1.51B |
Average Price | 64.04 | 88.41 |
Value | 899.67M | 1.51B |
Indicative Equilibrium Price | 64 | 89 |
Indicative Equilibrium Volume | 100 | 3.32K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.
Read more on IKAN →